19/120
0.8 / 5 stars
All 120 Win/Lose results shown below
STOK Roast Me summary
Stoke Therapeutics, Inc. (STOK). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSTOK / S&P 0.49% / 15.20% |
LoseSTOK / S&P -86.20% / 15.00% |
LoseSTOK / S&P -488.37% / 50.40% |
| 2026-Q11/3 |
WinSTOK / S&P 2.58% / -4.33% |
LoseSTOK / S&P -83.20% / 11.30% |
LoseSTOK / S&P -451.25% / 27.70% |
| 2025-Q42/3 |
WinSTOK / S&P 35.06% / 2.65% |
WinSTOK / S&P 404.50% / 9.00% |
LoseSTOK / S&P STOK unavailable / 13.40% |
| 2025-Q32/3 |
WinSTOK / S&P 107.05% / 8.12% |
WinSTOK / S&P 1128.17% / 4.61% |
LoseSTOK / S&P STOK unavailable / 13.45% |
| 2025-Q22/3 |
WinSTOK / S&P 70.68% / 10.94% |
WinSTOK / S&P 1218.82% / 4.83% |
LoseSTOK / S&P STOK unavailable / 10.63% |
| 2025-Q11/3 |
LoseSTOK / S&P -39.71% / -4.27% |
WinSTOK / S&P 2333.50% / 4.98% |
LoseSTOK / S&P STOK unavailable / 10.57% |
| 2024-Q41/3 |
LoseSTOK / S&P -10.25% / 2.41% |
WinSTOK / S&P 316.34% / 5.25% |
LoseSTOK / S&P STOK unavailable / 6.15% |
| 2024-Q31/3 |
LoseSTOK / S&P -9.03% / 5.89% |
WinSTOK / S&P 81.06% / 5.89% |
LoseSTOK / S&P STOK unavailable / 6.11% |
| 2024-Q21/3 |
LoseSTOK / S&P 0.07% / 4.28% |
WinSTOK / S&P 71.38% / 5.38% |
LoseSTOK / S&P STOK unavailable / 5.12% |
| 2024-Q11/3 |
WinSTOK / S&P 156.65% / 10.56% |
LoseSTOK / S&P -46.10% / 5.71% |
LoseSTOK / S&P STOK unavailable / 5.59% |
| 2023-Q41/3 |
WinSTOK / S&P 33.50% / 11.69% |
LoseSTOK / S&P -29.22% / 6.81% |
LoseSTOK / S&P STOK unavailable / 7.78% |
| 2023-Q30/3 |
LoseSTOK / S&P -62.94% / -3.27% |
LoseSTOK / S&P STOK unavailable / 7.52% |
LoseSTOK / S&P STOK unavailable / -5.03% |
| 2023-Q21/3 |
WinSTOK / S&P 27.61% / 8.74% |
LoseSTOK / S&P STOK unavailable / 9.50% |
LoseSTOK / S&P STOK unavailable / -8.57% |
| 2023-Q10/3 |
LoseSTOK / S&P -9.75% / 7.50% |
LoseSTOK / S&P STOK unavailable / 10.77% |
LoseSTOK / S&P STOK unavailable / -15.69% |
| 2022-Q40/3 |
LoseSTOK / S&P -28.12% / 7.56% |
LoseSTOK / S&P STOK unavailable / 11.88% |
LoseSTOK / S&P STOK unavailable / -17.99% |
| 2022-Q31/3 |
WinSTOK / S&P -2.80% / -4.88% |
LoseSTOK / S&P STOK unavailable / 13.47% |
LoseSTOK / S&P STOK unavailable / -1.41% |
| 2022-Q20/3 |
LoseSTOK / S&P -37.24% / -16.10% |
LoseSTOK / S&P STOK unavailable / 13.71% |
LoseSTOK / S&P STOK unavailable / 11.04% |
| 2022-Q10/3 |
LoseSTOK / S&P -12.26% / -4.60% |
LoseSTOK / S&P STOK unavailable / 15.97% |
LoseSTOK / S&P STOK unavailable / 42.23% |
| 2021-Q40/3 |
LoseSTOK / S&P -5.70% / 11.03% |
LoseSTOK / S&P STOK unavailable / 15.00% |
LoseSTOK / S&P STOK unavailable / 96.40% |
| 2021-Q30/3 |
LoseSTOK / S&P -24.42% / 0.58% |
LoseSTOK / S&P STOK unavailable / 10.77% |
LoseSTOK / S&P STOK unavailable / 69.42% |
| 2021-Q20/3 |
LoseSTOK / S&P -13.34% / 8.55% |
LoseSTOK / S&P STOK unavailable / 6.58% |
LoseSTOK / S&P STOK unavailable / 51.81% |
| 2021-Q10/3 |
LoseSTOK / S&P -37.28% / 6.17% |
LoseSTOK / S&P STOK unavailable / -1.06% |
LoseSTOK / S&P STOK unavailable / 7.39% |
| 2020-Q41/3 |
WinSTOK / S&P 84.92% / 12.15% |
LoseSTOK / S&P STOK unavailable / -3.72% |
LoseSTOK / S&P STOK unavailable / -33.42% |
| 2020-Q31/3 |
WinSTOK / S&P 40.54% / 8.93% |
LoseSTOK / S&P STOK unavailable / -2.04% |
LoseSTOK / S&P STOK unavailable / -27.10% |
| 2020-Q20/3 |
LoseSTOK / S&P 4.06% / 20.54% |
LoseSTOK / S&P STOK unavailable / -0.46% |
LoseSTOK / S&P STOK unavailable / -27.11% |
| 2020-Q11/3 |
WinSTOK / S&P -19.14% / -19.60% |
LoseSTOK / S&P STOK unavailable / 3.47% |
LoseSTOK / S&P STOK unavailable / -14.75% |
| 2019-Q41/3 |
WinSTOK / S&P 31.78% / 9.07% |
LoseSTOK / S&P STOK unavailable / 5.36% |
LoseSTOK / S&P STOK unavailable / 2.99% |
| 2019-Q30/3 |
LoseSTOK / S&P -26.33% / 1.70% |
LoseSTOK / S&P STOK unavailable / 5.02% |
LoseSTOK / S&P STOK unavailable / 0.21% |
| 2019-Q20/3 |
LoseSTOK / S&P STOK unavailable / 4.30% |
LoseSTOK / S&P STOK unavailable / 6.64% |
LoseSTOK / S&P STOK unavailable / 8.65% |
| 2019-Q10/3 |
LoseSTOK / S&P STOK unavailable / 13.65% |
LoseSTOK / S&P STOK unavailable / 8.12% |
LoseSTOK / S&P STOK unavailable / 14.29% |
| 2018-Q40/3 |
LoseSTOK / S&P STOK unavailable / -13.52% |
LoseSTOK / S&P STOK unavailable / 9.05% |
LoseSTOK / S&P STOK unavailable / 18.23% |
| 2018-Q30/3 |
LoseSTOK / S&P STOK unavailable / 7.71% |
LoseSTOK / S&P STOK unavailable / 10.21% |
LoseSTOK / S&P STOK unavailable / 19.06% |
| 2018-Q20/3 |
LoseSTOK / S&P STOK unavailable / 3.43% |
LoseSTOK / S&P STOK unavailable / 9.03% |
LoseSTOK / S&P STOK unavailable / 14.46% |
| 2018-Q10/3 |
LoseSTOK / S&P STOK unavailable / -0.76% |
LoseSTOK / S&P STOK unavailable / 7.68% |
LoseSTOK / S&P STOK unavailable / 12.46% |
| 2017-Q40/3 |
LoseSTOK / S&P STOK unavailable / 6.64% |
LoseSTOK / S&P STOK unavailable / 7.03% |
LoseSTOK / S&P STOK unavailable / 13.82% |
| 2017-Q30/3 |
LoseSTOK / S&P STOK unavailable / 4.48% |
LoseSTOK / S&P STOK unavailable / 5.68% |
LoseSTOK / S&P STOK unavailable / 17.57% |
| 2017-Q20/3 |
LoseSTOK / S&P STOK unavailable / 3.09% |
LoseSTOK / S&P STOK unavailable / 4.83% |
LoseSTOK / S&P STOK unavailable / 17.74% |
| 2017-Q10/3 |
LoseSTOK / S&P STOK unavailable / 6.07% |
LoseSTOK / S&P STOK unavailable / 3.67% |
LoseSTOK / S&P STOK unavailable / 13.32% |
| 2016-Q40/3 |
LoseSTOK / S&P STOK unavailable / 3.82% |
LoseSTOK / S&P STOK unavailable / 2.09% |
LoseSTOK / S&P STOK unavailable / 7.05% |
| 2016-Q30/3 |
LoseSTOK / S&P STOK unavailable / 3.85% |
LoseSTOK / S&P STOK unavailable / 0.20% |
LoseSTOK / S&P STOK unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | STOK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 59.72% | 20.78% |
| Annualized return | 59.72% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | STOK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 19.10% | 83.14% |
| Annualized return | 3.56% | 12.86% |
10Y · 2019-06-19 to 2026-08-28
| Metric | STOK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 23.43% | 319.30% |
| Annualized return | 2.13% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |